baber/WOPTO huggingface dataset:
Patent NZ-595075-A (NZ)
Title: Method for manufacturing permeable paving with a sub base containing hollow bodies with apertures
Inventor: CHEN JUI-WEN
IPC: E01C13/02
Filed: 2011-09-08
Abstract: 595075 A method for manufacturing artificial paving that helps improving global warming, mainly constituted by an ecological gradation layer 10 and a water permeable paving layer 40, where after ground leveling, an ecological gradation layer 10 is laid first. The layer 10 is formed of gradation materials for road construction or on-site earth. Hollow bodies 11 are then mixed in the earth. Each hollow body 11 comprises a shell composed of two halved shell members joined to each other to define an interior space. The shell members have through apertures communicating with the interior space. The hollow bodies and the gradation earth are mixed and laid and then subjected to pressurization for ramming. A water permeable paving layer 40 is set on the ecological gradation layer 10, where rainwater falling on ground is allowed to effectively permeate the artificially set layers to reach an underground water stratum 60 that is located under an underground soil stratum, so that rainwater is conducted to the underground water stratum. The interior space defined between the shell members of each of the hollow bodies 10 contained in the ecological gradation layer-provide an excellent survival environment for microorganisms and protozoa.
Patent NZ-595423-A (NZ)
Title: Forehead supports for facial masks
Inventor: CHU VINCENT
IPC: A61M16/06
Filed: 2007-06-15
Abstract: 595423 Disclosed is a mask assembly to supply breathable gas to a patient with adjustable forehead supports for improved comfort and sealing. The mask assembly comprises a mask frame; a cushion provided to the mask frame; and a forehead support. The forehead support comprises a frame connector extending from an upper portion of the mask frame and having an outer housing and an internal ring supported within the outer housing; an actuator disposed on the frame connector; and a forehead cushion support. The forehead cushion support comprises at least one forehead cushion support plate to carry at least one forehead cushion; and a tube having a distal end and a proximal end, the proximal end attached to the at least one forehead cushion support plate, the tube slidably attached to the frame connector along a linear adjustment path defined by the internal ring such that at least the distal end of the tube is enclosed within the housing in an extended position and a retracted position. At least two protrusions and at least two corresponding keyways are configured to prevent the tube from rotating about its longitudinal axis within the ring between the extended position and the retracted position. The actuator adjustably secures the tube to the frame connector along the linear adjustment path. Position markings are provided on the tube to indicate a position of the tube and include artwork formed by pad-printing, etching, laser-etching, and/or in-mold decoration.
Patent NZ-598482-A (NZ)
Title: Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
Inventor: KARMALI RASHIDA A
IPC: A01N43/82
Filed: 2010-09-03
Abstract: 598482 Disclosed is a compound comprising polymorphic form 1 or 2 of 5-amino-1-(4-(4- chlorobenzoyl)-3,5-dichlorobenzyl)-1,2,3-triazole-4-carboxamide with orotic acid having a powder x-ray diffraction pattern comprising peaks at 28 of 4.9, 20.2, 24.3, 26.5 and 28.7; or 19.5, 23.2, 25, 28.7 and 29 respectively. Also disclosed is the orotate salt of the compound. The compounds are useful for the treatment of solid cancers, macular degeneration, retinopathy, chronic myeloid leukaemia or AIDS.
Patent NZ-603284-A (NZ)
Title: Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Inventor: CATRON NATHANIEL D
IPC: A01N43/38
Filed: 2011-05-25
Abstract: Disclosed herein is a compound of formula (I), (II) or (III), wherein the variables are defined herein, and the use in the treatment of bladder cancer, brain cancer, breast cancer, bone marrow cancer, cervical cancer, chronic lymphocytic leukemia, colorectal cancer, esophageal cancer, hepatocellular cancer, lymphoblastic leukemia, follicular lymphoma, lymphoidmalignancies of T -cell or B-cell origin, melanoma, myelogenous leukemia, myeloma, oral cancer, ovarian cancer, non-small cell lung cancer, chronic lymphocytic leukemia, myeloma, prostate cancer, small cell lung cancer or spleen cancer Embodiments of the compound include the following: (5-{ 5-(4-{ [2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl} piperazin-1-yl)-2-[({ 3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl} sulfonyl)carbamoyl] phenoxy} -7H-pyrrolo[2,3-b]pyridin-7-yl)methyldihydrogen phosphate; and trans-4-[(4-{ [4-(4-{ [2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl} piperazin-1-yl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzoyl]sulfamoyl} -2-nitrophenoxy)methyl]cyclohexyldihydrogen phosphate
Patent NZ-607480-A (NZ)
Title: Dual variable domain immunoglobulins and uses thereof
Inventor: LIU JUNJIAN
IPC: C07K16/00
Filed: 2011-08-02
Abstract: Discloses a binding protein comprising first and second polypeptide chains, each independently comprising VD-(X1)n-VD2-C-(X2)n, wherein the VD1 and VD2 domains form functional binding sites, wherein the functional binding sites bind to IL-1B and are comprised of the following CDR sequences. CDR H1 - RYDMS CDR H2 - YISHGGAGTYYPDSVK CDR H3 - YFDVWGQG CDR L1 - RASGNIHNYLT CDR L2 - NAKTLA CDR L3 - QHFWSIPY
Patent NZ-614081-A (NZ)
Title: Auto-injector
Inventor: EKMAN MATTHEW
IPC: A61M5/32
Filed: 2012-02-16
Abstract: An auto-injector (1) for administering a dose of a liquid medicament (M) is disclosed. After the liquid medicament has been injected the injection needle is automatically retracted. The auto-injector has a tubular chassis (2) telescopable in a tubular case (12) and a carrier subassembly comprising a tubular carrier (7) slidably arranged relative to the chassis (2) inside the case (12). The carrier (7) is adapted to contain a syringe (3) with a hollow injection needle (4), a drive spring (8) and a plunger (9) for forwarding load of the drive spring (8) to a stopper (6) of the syringe (3). The syringe (3) is lockable for joint axial translation with the carrier (7). A trigger button (13) is arranged distally or laterally in or on the case (12). A control spring (19) is arranged around the carrier (7) with a needle extension control mechanism (24) for coupling a proximal end of the control spring (19) to either the carrier (7) for advancing it for needle extension or to the chassis (2) for needle retraction depending on the relative axial position of the carrier (7) and the chassis (2). A plunger release mechanism (27) is arranged for releasing the plunger (9) for injection when the carrier (7) has at least almost reached an extended proximal position. Adetent mechanism (18) is arranged for coupling the chassis (2) to the carrier (7) for joint axial translation relative to the case (12), wherein the detent mechanism (18) decouples the chassis (2) from the carrier (7) upon actuation of the trigger button (13) thus allowing the carrier (7) to move relative to the chassis (2) so as to cause the needle extension control mechanism (24) to switch the proximal end of the control spring (19) to the carrier (7) for needle extension. A syringe retraction control mechanism (25) is arranged for coupling a distal end of the control spring (19) to either the carrier (7) for needle retraction or to the case (12) otherwise.
Patent NZ-619259-A (NZ)
Title: Inhibitors of influenza viruses replication
Inventor: SALITURO FRANCESCO G
IPC: A61P31/16
Filed: 2010-06-17
Abstract: Disclosed herein are methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (IA): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Patent NZ-623816-A (NZ)
Title: Non-alcoholic beverage containing eudesmol
Inventor: OHARA KAZUAKI
IPC: A61P25/02
Filed: 2012-09-06
Abstract: Provided is a non-alcoholic beverage, which has an autonomic nerve modulating effect, shows an excellent cool taste and has an alcohol content of less than 1%, characterized by comprising, as the active component, one or more kinds of eudesmols selected from among α-eudesmol, β-eudesmol and γ-eudesmol and the content of the active component being 5-100 ppb. Also provided is an autonomic nerve modulating agent characterized by comprising, as the active component, the eudesmol(s) contained in the aforesaid beverage and the content of the active component, in terms of the total content of the eudesmol(s) therein, being 5-100 ppb.
Patent NZ-627977-A (NZ)
Title: Humanized rodents that express heavy chains containing vl domains
Inventor: MACDONALD LYNN
IPC: C12N9/64
Filed: 2013-02-01
Abstract: Disclosed is a rodent comprising one or more human VL gene segments and one or more human JL gene segments operably linked to a non-human immunoglobulin heavy chain constant region gene, wherein the rodent expresses one or more rodent ADAM6 proteins or functional fragments thereof from an inserted nucleic acid sequence. Also disclosed is a non-human animal whose genome comprises: (a) an insertion of one or more human VL gene segments and one or more human JL gene segments upstream of an non-human immunoglobulin light chain constant region gene, wherein the one or more human VL gene segments and one or more human JL gene segments are operably linked to the non-human immunoglobulin light chain constant region gene, (b) an insertion of one more human VL gene segments and one or more human JL gene segments upstream of an non-human immunoglobulin heavy chain constant region gene, wherein the one or more human VL gene segments and one or more human JL gene segments are operably linked to the non-human immunoglobulin heavy chain constant region gene, and (c) an inserted nucleic acid sequence that encodes a rodent ADAM6 protein or a functional fragment thereof, wherein the rodent ADAM6 protein or functional fragment thereof is expressed from the inserted nucleic acid sequence, so that B cells of the non-human animal express antibodies that each include two immunoglobulin light chains paired with two immunoglobulin heavy chains, wherein each light chain comprises a human light chain variable domain and a non-human light chain constant domain and each heavy chain comprises a human light chain variable domain and a non-human heavy chain constant domain.
Patent NZ-630868-A (NZ)
Title: Acellular pertussis vaccine
Inventor: POOLMAN JAN THEUNIS
IPC: A61K39/002
Filed: 2014-03-06
Abstract: Disclosed is an acellular pertussis (aP) vaccine composition comprising Bordetella pertussis antigens, pertussis toxoid (PT), filamentous haemagglutinin (FHA), and fimbriae types 2 and 3 (FIM), wherein FIM is present in an amount 5 of 12-100 μg per human dose. Also disclosed is the use of said composition in the manufacture of a vaccine for vaccinating a subject against Bordetella pertussis.
Patent NZ-706642-A (NZ)
Title: Rheologically stable aqueous mineral material suspensions comprising organic polymers having reduced volatile organic compound (voc) content
Inventor: GANE PATRICK A C
IPC: C08F20/06
Filed: 2013-09-20
Abstract: The present invention relates to a rheologically stable aqueous mineral material suspension comprising organic polymers having reduced volatile organic compounds (VOCs) to overcome the problem of contamination as a result of the VOCs. Specifically, the invention provides a rheologically stable aqueous mineral material suspension comprising: a) at least one mineral material, and b) at least one polymer of acrylic and/or methacrylic acid, wherein the at least one polymer of acrylic and/or methacrylic acid - wherein is obtained by polymerization of acrylic and/or methacrylic acid monomer(s) in water using a compound of formula (I) wherein - X represents Li, Na, K or H, and - R represents an alkyl chain comprising 1 to 5 carbon atoms, and wherein the compound of formula (I) is used in an amount of from 0.1 to 2.5 wt%, based on the weight of said monomer(s); - has a weight molecular weight Mw of from 800 to 8000 g/mol; - has a polydispersity index Ip in the range from 2 to 3; and wherein the aqueous mineral material suspension has a content of volatile organic compounds (VOC) of ≤ 20 mg/kg.
Patent NZ-711986-A (NZ)
Title: Plant regulatory elements and uses thereof
Inventor: CHITTOOR JAISHREE
IPC: C12N15/00
Filed: 2014-03-11
Abstract: The invention provides recombinant DNA molecules and constructs, as well as their nucleotide sequences, useful for modulating gene expression in plants. The invention also provides transgenic plants, plant cells, plant parts, and seeds comprising a recombinant DNA molecule comprising a DNA molecule operably linked to heterologous transcribable DNA molecule, as are methods of their use.
Patent NZ-720450-A (NZ)
Title: Cryptographic watermarking of content in fuel dispensing environments
Inventor: CARAPELLI GIOVANNI
IPC: H04L9/32
Filed: 2014-10-30
Abstract: Systems and methods for watermarking content and authenticating watermarked content are provided. Content is rendered on a display while watermarking information embedded in portions of the content are obtained. The watermarking information is verified to authenticate the content. If the content is not authentic, or is not authenticated within a period of time, the content can be terminated or otherwise blocked from rendering on the display.
Patent NZ-723994-A (NZ)
Title: Transdermal compositions of ibuprofen and methods of use thereof
Inventor: CHEN HAIGANG
IPC: A61K47/38
Filed: 2012-05-03
Abstract: Disclosed is a composition for transdermal administration comprising S-ibuprofen, or a salt thereof, wherein about 5% by weight of the composition is S-ibuprofen; a gelling agent selected from the group consisting of methyl cellulose, ethyl cellulose, hydroxycellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, and mixtures thereof; propylene glycol; isopropyl myristate; a lower alkyl alcohol selected from the group consisting of ethanol, propanol, isopropyl alcohol, and mixtures thereof; and water; wherein the composition has an apparent pH of 7.0; on the proviso that the viscosity is not 10,000 to 50,000 cps. Also disclosed is the use of the composition for the treatment of pain and inflammation.
Patent NZ-725281-A (NZ)
Title: Twist tie dispensing apparatus and method
Inventor: TSCHETTER JEFFREY
IPC: B65D73/00
Filed: 2015-07-02
Abstract: Apparatus (100, 200, 400, 500, 600) including a stack (110, 310) having a plurality of connected tie web sheets (106, 306) and an image (114) disposed on each of the tie web sheets (106, 306), wherein the image (114) is the same on each tie web sheet (106, 306) and is disposed in overlay registration from sheet (106, 306) to sheet (106, 306). A method of dispensing a plurality of twist ties (104, 304) includes mounting a stack (110, 310) within reach of a user and displaying an image (114) disposed on each of the tie web sheets (106, 306). Removal of a twist tie (104, 304) of the plurality of twist ties (104, 304) of the stack (110, 310) does not alter the image (114) viewable by the user.
Patent NZ-728885-A (NZ)
Title: A method of making eyewear frame having sections joined with nose bridge
Inventor: SHELDON BRENT
IPC: G02C5/02
Filed: 2015-06-29
Abstract: A method of making an eyewear frame having substantially rigid sections joined with a soft and/or flexible nose bridge. The substantially rigid sections and soft and/or flexible nose bridge are made in separate molding processes. The cured substantially rigid sections and cured soft and/or flexible nose bridge are then joined together in a further molding process by injecting a bonding material into interfaces between the soft and/or flexible nose bridge and the respective substantially rigid sections. The eyewear frame may be painted. A pre-painting surface treatment may be applied to the soft and/or flexible nose bridge before it is joined with the substantially rigid right and left sections. The method provides an improved way to bond flexible eyewear frame parts and allow for secure attachment of lenses.
Patent NZ-742210-A (NZ)
Title: Neospora vaccine composition
Inventor: REGIDOR CERRILLO JAVIER
IPC: A61K39/002
Filed: 2016-10-28
Abstract: The present invention relates to new protein compositions, methods for producing said protein compositions, pharmaceutical compositions comprising said protein compositions and methods for treating infections caused by Neospora caninum. In particular, the present invention relates to a protein composition comprising the proteins specified in Table A in an amount of at least about 2 times (fold change) higher than the same protein present in the whole tachyzoite, as calculated by quantitative label-free liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Patent NZ-742608-A (NZ)
Title: Consolidating spacer fluids and methods of use
Inventor: RODDY CRAIG W
IPC: C09K8/60
Filed: 2013-12-20
Abstract: Disclosed are consolidating spacer fluids and methods of use in subterranean formations. Embodiments may include use of consolidating spacer fluids in displacement of drilling fluids from a well bore annulus. The consolidating spacer fluid comprises a cement kiln dust in an amount from about 80% to about 100% dry weight solids and at least one additive, whereby the consolidating spacer fluid has a density in a range of from about 1200 kg/m3 to about 1680 kg/m3. At least a portion of the consolidating spacer fluid is allowed to consolidate in the well bore annulus. The portion of the consolidating spacer fluid has a zero gel time of about 4 hours or less. A method of evaluating a spacer fluid for use in separating a drilling fluid and a cement composition in a well bore is also disclosed.
Patent NZ-742715-A (NZ)
Title: Foaming apparatus and method of use
Inventor: JOHNSON PETER STUART
IPC: A47J43/28
Filed: 2016-10-24
Abstract: The present invention relates to a method for using a foaming apparatus to foam liquid foods or beverages such as an egg white based liquid, wherein the apparatus includes an enclosure with a first and second cavity located therein wherein the enclosure includes at least one zone of constriction having multiple channels defined by internal surface(s) of the enclosure located between the first cavity and the second cavity in the enclosure, wherein the at least one zone of constriction allows the only transfer of a material between the first cavity and second cavity. The method includes steps of adding a gas to the apparatus interior and applying a force to the exterior of the first and second cavities alternatively to transfer the liquid food back and forth via the channels to foam the food. The method of using this foaming apparatus gives a quicker and more portable solution compared to the prior art.
Patent NZ-753586-A (NZ)
Title: System for managing packages of shuffled playing cards
Inventor: SHIGETA YASUSHI
IPC: A63F1/00
Filed: 2014-10-20
Abstract: The purpose of the present invention is to prevent unauthorized replacement of cards in a casino, and for this purpose, a system for managing packages (CA) has: packages (CA) of shuffled playing cards in which playing cards constituting a deck of a prescribed number of cards are shuffled in random order and each card is individually packed in one package (CA), a unique ID code (30) being assigned for each unique package (CA); a game table (11); a storage box (501) arranged to the side of the game table (11), the storage box (501) storing a plurality of packages (CA) and being provided with a reader (551) for reading in the ID codes (30) of all of the packages (CA), and lids (452a, 452b) capable of opening and closing so as to allow one package at a time to be removed; and a control device or monitoring whether or not the packages (CA) are in the storage box (501) by monitoring the ID codes (30) of the packages (CA) read in by the reader (551), and then outputting the result of said monitoring.
Patent NZ-755979-A (NZ)
Title: Metal-molybdate and method for making the same
Inventor: RUSSELL II WILLIAM EARL
IPC: B01J13/02
Filed: 2018-02-23
Abstract: A process for producing a metal-molybdate material is provided. The process includes a step of reacting a metal molybdenum (Mo) material in a liquid medium with a first acid to provide a Mo composition and combining the Mo composition with a metal source to provide a metal-Mo composition. The metal-Mo composition can be pH adjusted with a base to precipitate a plurality of metal-Mo particulates.
Patent NZ-756038-A (NZ)
Title: Mems scanning display device
Inventor: TARDIF JOHN ALLEN
IPC: G02B26/10
Filed: 2018-02-27
Abstract: The invention relates to near-eye (e.g., heads-up) scanning image display systems. A scanning head-mounted display system includes a light source, a motion sensor, a MEMS-based scanning mirror system configured to scan light from the light source to form an image, and a controller configured to control the scanning mirror system to scan the light to form the image, receive head motion data from the motion sensor, determine a likely head velocity from the head motion data, and adjust one or more of a scan rate and a phase offset between a first frame and a second frame of the image based upon the likely head velocity. The invention addresses the prior art limitations of display resolution in near-eye displays, while compensating for head motion.